Defects in Ankyrin-Based Membrane Protein Targeting Pathways Underlie Atrial Fibrillation
Shane R. Cunha(Cardiovascular Research Center), Peter J. Mohler(The Ohio State University Wexner Medical Center), Thomas J. Hund(The Ohio State University Wexner Medical Center), Dobromir Dobrev(University of Duisburg-Essen), Niels Voigt(Universitätsmedizin Göttingen), Seyed Hashemi(University of Iowa), Jean‐Jacques Schott(Centre National de la Recherche Scientifique), Hjalti Gudmundsson(University of Iowa), Mark E. Anderson(Johns Hopkins University), Hervé Le Marec(Centre National de la Recherche Scientifique), Olha M. Koval(Cardiovascular Research Center), Richard J. Gumina(The Ohio State University Wexner Medical Center), Na Li(China University of Mining and Technology), Jingdong Li(Sun Yat-sen University), Matthias Karck(Heidelberg University), Xander H.T. Wehrens(Baylor College of Medicine), Patrick Wright(University of Iowa), Vincent Probst(Centre National de la Recherche Scientifique)
Cited by 111
Related Papers
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
|Heart Rhythm|2011|1.5k
Congenital Heart Disease Caused by Mutations in the Transcription Factor <i>NKX2-5</i>
|Science|1998|1.3k